News & Updates

Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients
Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients
08 Apr 2022 byNatalia Reoutova

A retrospective study of over 6,000 Chinese patients with acute coronary syndrome (ACS) who underwent first-ever percutaneous coronary intervention (PCI) has shown that use of potent P2Y12 inhibitors, such as ticagrelor and prasugrel, is associated with lower risk of stroke than clopidogrel.

Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients
08 Apr 2022
Add-on amantadine lessens “off” episodes in Parkinson’s disease
Add-on amantadine lessens “off” episodes in Parkinson’s disease
06 Apr 2022
Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
01 Apr 2022 byJairia Dela Cruz

In the treatment of patients with mild ischaemic stroke or transient ischaemic attack (TIA), the combination of cinnamon and aspirin outperforms aspirin alone at reducing the risk of 90-day recurrent stroke, as shown in a study.

Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
01 Apr 2022